Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
5 hedge funds and large institutions have $142K invested in Biostar Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $130K | +$150K | +26,953 | New |
|
2
California Public Employees Retirement System
Sacramento,
California
| $10K | +$11.2K | +2,017 | New |
|
|
U
3
UBS
Zurich,
Switzerland
| $1K | +$662 | +119 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $1K | +$795 | +143 | New |
|
5
Wells Fargo
San Francisco,
California
| – | +$356 | +64 | New |
|
BSPM Hedge Fund Activity: Q2 2013 in Review
5 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q2 2013, worth a combined $142K.
Buyers outnumbered sellers: 5 funds opened new BSPM positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
- 5 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $142K of Biostar Pharmaceuticals, Inc. stock for Q2 2013.
- 5 funds opened new Biostar Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +5 holders.
Based on aggregated 13F filings for Q2 2013.